AI 인텔리전스May 15, 2026AI 인텔리전스
기사
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.
The company is developing novel therapies to overcome resistance to cancer immunotherapy.
Data Cube AI 편집팀출처: PR Newswire
01
출처 브리프
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.